STAR Act Aims to Boost Pediatric Research

This week, President Trump signed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act, which is aimed at supporting pediatric cancer research. The legislation calls for expanding the collection of patient biospecimens and records, improving surveillance, and investigating pediatric survivorship.

Read More

Highlighting Pediatric Preclinical Drug Testing at the Annual Meeting 2018

The AACR’s Pediatric Cancer Working Group, which now boasts over 2,500 members, will hold a special scientific session at the Annual Meeting, where ongoing advances and existing challenges in cancer research will be discussed through the pediatric lens.

Read More